Search Results for: stem cells for ms

Perspectives: FDA warns umbilical firm & continues stream of “mini-warning” letters

umbilical-cord-blood, umbilical cord blood stem cells

Yesterday we learned that the FDA issued a warning letter to the cord stem cell firm, Cord for Life. In this warning, the FDA indicated that the firm’s product is actually a drug product and lacks necessary pre-market approvals. In addition, the agency highlighted apparent deviations from CGMP practices. The most important part of the […]

Perspectives: FDA warns umbilical firm & continues stream of “mini-warning” letters Read More »

KING 5 TV pulls odd Swedish Medical regen med infomercial off YouTube

Swedish-Adam-Pourcho-Regenerative-Medicine

Some unproven stem cell clinics just make things up, but when a big medical organization like Seattle’s largest nonprofit health firm, Swedish Medical Group, has a marketing segment on TV with what in my view are odd and inaccurate claims related to regenerative medicine, the negative impact could be far greater. The segment in question

KING 5 TV pulls odd Swedish Medical regen med infomercial off YouTube Read More »

Don’t mess with (mother) Nature: why risk taking on a powerhouse journal?

Dont-mess-with-mother-nature

When I was a kid there was this commercial on TV for Chiffon margarine (fake butter) with the slogan, “It’s not nice to fool mother nature!” As a kid I thought it was dumb but kind of funny. A modified version of that mother nature advertising slogan has become a cultural tagline. Don’t mess with

Don’t mess with (mother) Nature: why risk taking on a powerhouse journal? Read More »

‘So you don’t get eyeball in your hand’: Swedish Medical Center ‘infomercial’

Swedish-Adam-Pourcho-Regenerative-Medicine

Swedish Medical Center in Seattle is now marketing regenerative medicine therapies including some things that in my view are not really scientifically proven to work including via an infomercial. This is part of a bigger trend where more legit medical centers have begun selling regenerative medicine “treatments” that are still being developed. Sometimes they even

‘So you don’t get eyeball in your hand’: Swedish Medical Center ‘infomercial’ Read More »

History tells us to be more skeptical of He Jiankui’s CRISPR baby story

Fake-cloning

Could He Jiankui have faked part or all of his CRISPR babies story? If so, how? Why? Or to put it another way, almost everyone seems to be assuming the story is real, but should we be more skeptical? Should we flip things around and assume the story isn’t entirely kosher until proven otherwise? I once

History tells us to be more skeptical of He Jiankui’s CRISPR baby story Read More »

Hvad er stamceller?

Hvad er stamceller? means “What are stem cells?” This is part of our SCOPE stem cells not lost in translation project. Hvad er stamceller? Menneskekroppen indeholder hundredevis af forskellige celletyper, der er vigtige for vores daglige helbred. Disse celler er ansvarlige for at vores krop fungerer som den skal hver dag, dvs. hjertet slår, hjernen tænker,

Hvad er stamceller? Read More »

Hope on Parkinson’s front: Japan IPSC trial 1st patient

Fig-3i-Kikuchi-et-al.-Nature-2017-IPS-cell-Parkinsons-

In Parkinson’s Disease patients develop neurological dysfunction as they lose a special kind of brain cell called dopaminergic (or dopamine) neurons. While a number of different approaches to this disease have been studied for decades, nothing has proven particularly successful in slowing its progression. As a result there has been a big need for novel thinking

Hope on Parkinson’s front: Japan IPSC trial 1st patient Read More »

Magenta Therapeutics Good News-Bad News Trial Data

Magenta

Magenta Therapeutics is a biotech company with a portfolio including stem cell products. Their most well known investigational drug product is an expanded umbilical cord stem cell product called MGTA-456, an “ex-Novartis” product. Magenta just released new trial data on MGTA-456, which I see as a case of good news-bad news, and investors seem to

Magenta Therapeutics Good News-Bad News Trial Data Read More »